Leandro Jonata Carvalho Oliveira, MD Medical Oncologist at Grupo Oncoclinicas. Focused on Breast Cancer and Cancer Genetics, shared on LinkedIn:
“Mama Gramado 2025 Congress.
A congress of the highest scientific level, in which I had the honor and challenge of discussing the PADA-1 and SERENA-6 studies, addressing their potential to impact clinical practice in the management of metastatic hormone receptor-positive breast cancer.
This year also featured rich oncogenetics sessions, including integration with radiotherapy, reinforcing the importance of the theme in our reality.
Congratulations to the organizers for the excellent event and to colleagues for the always enriching discussions.”
More posts about Leandro Jonata Carvalho Oliveira.